Clinical Trial Update: CaOx Stone Prevention [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update shows that Icahn School of Medicine at Mount Sinai is recruiting for a calcium oxalate stone prevention study in kidney stones.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Stones

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Kidney Stones | Phase 4 | Status: RECRUITING